APO Research
Talk to an analyst

APO RESEARCH · REPORT

GnRH Analogues

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global GnRH Analogues Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025193 pages

Choose your research edition.

Industry ResearchGnRH Analogues Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal GnRH Analogues Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal GnRH Analogues Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GnRH Analogues Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal GnRH Analogues Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global GnRH Analogues market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for GnRH Analogues is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GnRH Analogues is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GnRH Analogues is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for GnRH Analogues is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GnRH Analogues include Chongqing Lummy Pharmaceutical, Changchun GeneScience Pharmaceuticals, Hybio Pharmaceutical, Luye Pharma, Livzon Pharmaceutical, Beijing Biote Pharmaceutical, Tolmar, TerSera Therapeutics and Takeda Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GnRH Analogues market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GnRH Analogues and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GnRH Analogues sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GnRH Analogues market size, projected growth trends, production technologies, key applications, and end-use industries.

GnRH Analogues Segment by Company

Chongqing Lummy Pharmaceutical

Changchun GeneScience Pharmaceuticals

Hybio Pharmaceutical

Luye Pharma

Livzon Pharmaceutical

Beijing Biote Pharmaceutical

Tolmar

TerSera Therapeutics

Takeda Pharmaceutical

Sanofi

Praecis Pharmaceuticals

Pfizer

Organon Pharmaceutical

Merck

Ipsen Pharma

Fuji Pharma

Ferring Pharmaceuticals

Endo International

AstraZeneca

AbbVie

GnRH Analogues Segment by Type

Agonist

Antagonist

GnRH Analogues Segment by Application

Medical Applications

Veterinary Applications

Others

GnRH Analogues Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GnRH Analogues market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GnRH Analogues and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GnRH Analogues.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GnRH Analogues market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GnRH Analogues manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of GnRH Analogues in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of GnRH Analogues in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. GnRH Analogues Industry Trends Table 2. GnRH Analogues Industry Drivers Table 3. GnRH Analogues Industry Opportunities and Challenges Table 4. GnRH Analogues Industry Restraints Table 5. Global GnRH Analogues Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global GnRH Analogues Revenue Market Share by Manufacturers (2021-2026) Table 7. Global GnRH Analogues Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global GnRH Analogues Sales Market Share by Manufacturers Table 9. Global GnRH Analogues Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global GnRH Analogues Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global GnRH Analogues Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global GnRH Analogues Manufacturers, Product Type & Application Table 13. Global GnRH Analogues Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global GnRH Analogues by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Agonist Table 17. Major Manufacturers of Antagonist Table 18. Global GnRH Analogues Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global GnRH Analogues Sales by Type (2021-2026) & (K Units) Table 20. Global GnRH Analogues Sales by Type (2027-2032) & (K Units) Table 21. Global GnRH Analogues Sales Market Share by Type (2021-2026) Table 22. Global GnRH Analogues Sales Market Share by Type (2027-2032) Table 23. Global GnRH Analogues Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global GnRH Analogues Revenue by Type (2021-2026) & (K Units) Table 25. Global GnRH Analogues Revenue by Type (2027-2032) & (K Units) Table 26. Global GnRH Analogues Revenue Market Share by Type (2021-2026) Table 27. Global GnRH Analogues Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Medical Applications Table 29. Major Manufacturers of Veterinary Applications Table 30. Major Manufacturers of Others Table 31. Global GnRH Analogues Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global GnRH Analogues Sales by Application (2021-2026) & (K Units) Table 33. Global GnRH Analogues Sales by Application (2027-2032) & (K Units) Table 34. Global GnRH Analogues Sales Market Share by Application (2021-2026) Table 35. Global GnRH Analogues Sales Market Share by Application (2027-2032) Table 36. Global GnRH Analogues Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global GnRH Analogues Revenue by Application (2021-2026) & (K Units) Table 38. Global GnRH Analogues Revenue by Application (2027-2032) & (K Units) Table 39. Global GnRH Analogues Revenue Market Share by Application (2021-2026) Table 40. Global GnRH Analogues Revenue Market Share by Application (2027-2032) Table 41. Global GnRH Analogues Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global GnRH Analogues Sales by Region (2021-2026) & (K Units) Table 43. Global GnRH Analogues Sales Market Share by Region (2021-2026) Table 44. Global GnRH Analogues Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global GnRH Analogues Sales Forecasted Market Share by Region (2027-2032) Table 46. North America GnRH Analogues Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America GnRH Analogues Sales by Country (2021-2026) & (K Units) Table 48. North America GnRH Analogues Sales by Country (2027-2032) & (K Units) Table 49. Europe GnRH Analogues Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe GnRH Analogues Sales by Country (2021-2026) & (K Units) Table 51. Europe GnRH Analogues Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific GnRH Analogues Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific GnRH Analogues Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific GnRH Analogues Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa GnRH Analogues Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa GnRH Analogues Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa GnRH Analogues Sales by Country (2027-2032) & (K Units) Table 58. Global GnRH Analogues Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global GnRH Analogues Revenue by Region (2021-2026) & (US$ Million) Table 60. Global GnRH Analogues Revenue by Region (2027-2032) & (US$ Million) Table 61. Global GnRH Analogues Revenue Market Share by Region (2021-2026) Table 62. Global GnRH Analogues Revenue Market Share by Region (2027-2032) Table 63. Chongqing Lummy Pharmaceutical Company Information Table 64. Chongqing Lummy Pharmaceutical Business Overview Table 65. Chongqing Lummy Pharmaceutical GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chongqing Lummy Pharmaceutical GnRH Analogues Product Portfolio Table 67. Chongqing Lummy Pharmaceutical Recent Development Table 68. Changchun GeneScience Pharmaceuticals Company Information Table 69. Changchun GeneScience Pharmaceuticals Business Overview Table 70. Changchun GeneScience Pharmaceuticals GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Changchun GeneScience Pharmaceuticals GnRH Analogues Product Portfolio Table 72. Changchun GeneScience Pharmaceuticals Recent Development Table 73. Hybio Pharmaceutical Company Information Table 74. Hybio Pharmaceutical Business Overview Table 75. Hybio Pharmaceutical GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hybio Pharmaceutical GnRH Analogues Product Portfolio Table 77. Hybio Pharmaceutical Recent Development Table 78. Luye Pharma Company Information Table 79. Luye Pharma Business Overview Table 80. Luye Pharma GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Luye Pharma GnRH Analogues Product Portfolio Table 82. Luye Pharma Recent Development Table 83. Livzon Pharmaceutical Company Information Table 84. Livzon Pharmaceutical Business Overview Table 85. Livzon Pharmaceutical GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Livzon Pharmaceutical GnRH Analogues Product Portfolio Table 87. Livzon Pharmaceutical Recent Development Table 88. Beijing Biote Pharmaceutical Company Information Table 89. Beijing Biote Pharmaceutical Business Overview Table 90. Beijing Biote Pharmaceutical GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Beijing Biote Pharmaceutical GnRH Analogues Product Portfolio Table 92. Beijing Biote Pharmaceutical Recent Development Table 93. Tolmar Company Information Table 94. Tolmar Business Overview Table 95. Tolmar GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Tolmar GnRH Analogues Product Portfolio Table 97. Tolmar Recent Development Table 98. TerSera Therapeutics Company Information Table 99. TerSera Therapeutics Business Overview Table 100. TerSera Therapeutics GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. TerSera Therapeutics GnRH Analogues Product Portfolio Table 102. TerSera Therapeutics Recent Development Table 103. Takeda Pharmaceutical Company Information Table 104. Takeda Pharmaceutical Business Overview Table 105. Takeda Pharmaceutical GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Takeda Pharmaceutical GnRH Analogues Product Portfolio Table 107. Takeda Pharmaceutical Recent Development Table 108. Sanofi Company Information Table 109. Sanofi Business Overview Table 110. Sanofi GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sanofi GnRH Analogues Product Portfolio Table 112. Sanofi Recent Development Table 113. Praecis Pharmaceuticals Company Information Table 114. Praecis Pharmaceuticals Business Overview Table 115. Praecis Pharmaceuticals GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Praecis Pharmaceuticals GnRH Analogues Product Portfolio Table 117. Praecis Pharmaceuticals Recent Development Table 118. Pfizer Company Information Table 119. Pfizer Business Overview Table 120. Pfizer GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Pfizer GnRH Analogues Product Portfolio Table 122. Pfizer Recent Development Table 123. Organon Pharmaceutical Company Information Table 124. Organon Pharmaceutical Business Overview Table 125. Organon Pharmaceutical GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Organon Pharmaceutical GnRH Analogues Product Portfolio Table 127. Organon Pharmaceutical Recent Development Table 128. Merck Company Information Table 129. Merck Business Overview Table 130. Merck GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Merck GnRH Analogues Product Portfolio Table 132. Merck Recent Development Table 133. Ipsen Pharma Company Information Table 134. Ipsen Pharma Business Overview Table 135. Ipsen Pharma GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Ipsen Pharma GnRH Analogues Product Portfolio Table 137. Ipsen Pharma Recent Development Table 138. Fuji Pharma Company Information Table 139. Fuji Pharma Business Overview Table 140. Fuji Pharma GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Fuji Pharma GnRH Analogues Product Portfolio Table 142. Fuji Pharma Recent Development Table 143. Ferring Pharmaceuticals Company Information Table 144. Ferring Pharmaceuticals Business Overview Table 145. Ferring Pharmaceuticals GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Ferring Pharmaceuticals GnRH Analogues Product Portfolio Table 147. Ferring Pharmaceuticals Recent Development Table 148. Endo International Company Information Table 149. Endo International Business Overview Table 150. Endo International GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Endo International GnRH Analogues Product Portfolio Table 152. Endo International Recent Development Table 153. AstraZeneca Company Information Table 154. AstraZeneca Business Overview Table 155. AstraZeneca GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. AstraZeneca GnRH Analogues Product Portfolio Table 157. AstraZeneca Recent Development Table 158. AbbVie Company Information Table 159. AbbVie Business Overview Table 160. AbbVie GnRH Analogues Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. AbbVie GnRH Analogues Product Portfolio Table 162. AbbVie Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. GnRH Analogues Distributors List Table 166. GnRH Analogues Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. GnRH Analogues Product Image Figure 2. Global GnRH Analogues Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GnRH Analogues Market Size (2021-2032) & (US$ Million) Figure 4. Global GnRH Analogues Sales (2021-2032) & (K Units) Figure 5. Global GnRH Analogues Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 GnRH Analogues Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Agonist Image Figure 9. Antagonist Image Figure 10. Global GnRH Analogues Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global GnRH Analogues Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global GnRH Analogues Sales Market Share by Type (2021-2032) Figure 13. Global GnRH Analogues Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global GnRH Analogues Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global GnRH Analogues Revenue Market Share by Type (2021-2032) Figure 16. Medical Applications Image Figure 17. Veterinary Applications Image Figure 18. Others Image Figure 19. Global GnRH Analogues Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global GnRH Analogues Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global GnRH Analogues Sales Market Share by Application (2021-2032) Figure 22. Global GnRH Analogues Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global GnRH Analogues Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global GnRH Analogues Revenue Market Share by Application (2021-2032) Figure 25. North America GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America GnRH Analogues Sales Market Share by Country (2021-2032) Figure 27. U.S. GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe GnRH Analogues Sales Market Share by Country (2021-2032) Figure 32. Germany GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific GnRH Analogues Sales Market Share by Country (2021-2032) Figure 39. China GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa GnRH Analogues Sales Market Share by Country (2021-2032) Figure 47. Brazil GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile GnRH Analogues Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global GnRH Analogues Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global GnRH Analogues Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America GnRH Analogues Revenue (2021-2032) & (US$ Million) Figure 58. North America GnRH Analogues Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe GnRH Analogues Revenue (2021-2032) & (US$ Million) Figure 60. Europe GnRH Analogues Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific GnRH Analogues Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific GnRH Analogues Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa GnRH Analogues Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa GnRH Analogues Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. GnRH Analogues Value Chain Figure 66. Manufacturing Cost Structure Figure 67. GnRH Analogues Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Agonist
  • Antagonist
Applications
  • Medical Applications
  • Veterinary Applications
  • Others
Companies covered
  • Chongqing Lummy Pharmaceutical
  • Changchun GeneScience Pharmaceuticals
  • Hybio Pharmaceutical
  • Luye Pharma
  • Livzon Pharmaceutical
  • Beijing Biote Pharmaceutical
  • Tolmar
  • TerSera Therapeutics
  • Takeda Pharmaceutical
  • Sanofi
  • Praecis Pharmaceuticals
  • Pfizer
  • Organon Pharmaceutical
  • Merck
  • Ipsen Pharma
  • Fuji Pharma
  • Ferring Pharmaceuticals
  • Endo International
  • AstraZeneca
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global GnRH Analogues Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global GnRH Analogues Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global GnRH Analogues Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global GnRH Analogues Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global GnRH Analogues Market Dynamics
  1. 2.1 GnRH Analogues Industry Trends
  2. 2.2 GnRH Analogues Industry Drivers
  3. 2.3 GnRH Analogues Industry Opportunities and Challenges
  4. 2.4 GnRH Analogues Industry Restraints
3 GnRH Analogues Market by Manufacturers
  1. 3.1 Global GnRH Analogues Revenue by Manufacturers (2021-2026)
  2. 3.2 Global GnRH Analogues Sales by Manufacturers (2021-2026)
  3. 3.3 Global GnRH Analogues Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global GnRH Analogues Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GnRH Analogues Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global GnRH Analogues Manufacturers, Product Type & Application
  7. 3.7 Global GnRH Analogues Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GnRH Analogues Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GnRH Analogues Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GnRH Analogues Tier 1, Tier 2, and Tier 3
4 GnRH Analogues Market by Type
  1. 4.1 GnRH Analogues Type Introduction
  2. 4.1.1 Agonist
  3. 4.1.2 Antagonist
  4. 4.2 Global GnRH Analogues Sales by Type
  5. 4.2.1 Global GnRH Analogues Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global GnRH Analogues Sales by Type (2021-2032)
  7. 4.2.3 Global GnRH Analogues Sales Market Share by Type (2021-2032)
  8. 4.3 Global GnRH Analogues Revenue by Type
  9. 4.3.1 Global GnRH Analogues Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global GnRH Analogues Revenue by Type (2021-2032)
  11. 4.3.3 Global GnRH Analogues Revenue Market Share by Type (2021-2032)
5 GnRH Analogues Market by Application
  1. 5.1 GnRH Analogues Application Introduction
  2. 5.1.1 Medical Applications
  3. 5.1.2 Veterinary Applications
  4. 5.1.3 Others
  5. 5.2 Global GnRH Analogues Sales by Application
  6. 5.2.1 Global GnRH Analogues Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global GnRH Analogues Sales by Application (2021-2032)
  8. 5.2.3 Global GnRH Analogues Sales Market Share by Application (2021-2032)
  9. 5.3 Global GnRH Analogues Revenue by Application
  10. 5.3.1 Global GnRH Analogues Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global GnRH Analogues Revenue by Application (2021-2032)
  12. 5.3.3 Global GnRH Analogues Revenue Market Share by Application (2021-2032)
6 Global GnRH Analogues Sales by Region
  1. 6.1 Global GnRH Analogues Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GnRH Analogues Sales by Region (2021-2032)
  3. 6.2.1 Global GnRH Analogues Sales by Region (2021-2026)
  4. 6.2.2 Global GnRH Analogues Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America GnRH Analogues Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America GnRH Analogues Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe GnRH Analogues Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe GnRH Analogues Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific GnRH Analogues Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific GnRH Analogues Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa GnRH Analogues Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa GnRH Analogues Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global GnRH Analogues Revenue by Region
  1. 7.1 Global GnRH Analogues Revenue by Region
  2. 7.1.1 Global GnRH Analogues Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global GnRH Analogues Revenue by Region (2021-2026)
  4. 7.1.3 Global GnRH Analogues Revenue by Region (2027-2032)
  5. 7.1.4 Global GnRH Analogues Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America GnRH Analogues Revenue (2021-2032)
  8. 7.2.2 North America GnRH Analogues Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe GnRH Analogues Revenue (2021-2032)
  11. 7.3.2 Europe GnRH Analogues Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific GnRH Analogues Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific GnRH Analogues Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa GnRH Analogues Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa GnRH Analogues Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Lummy Pharmaceutical
  2. 8.1.1 Chongqing Lummy Pharmaceutical Company Information
  3. 8.1.2 Chongqing Lummy Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Lummy Pharmaceutical GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Lummy Pharmaceutical GnRH Analogues Product Portfolio
  6. 8.1.5 Chongqing Lummy Pharmaceutical Recent Developments
  7. 8.2 Changchun GeneScience Pharmaceuticals
  8. 8.2.1 Changchun GeneScience Pharmaceuticals Company Information
  9. 8.2.2 Changchun GeneScience Pharmaceuticals Business Overview
  10. 8.2.3 Changchun GeneScience Pharmaceuticals GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Changchun GeneScience Pharmaceuticals GnRH Analogues Product Portfolio
  12. 8.2.5 Changchun GeneScience Pharmaceuticals Recent Developments
  13. 8.3 Hybio Pharmaceutical
  14. 8.3.1 Hybio Pharmaceutical Company Information
  15. 8.3.2 Hybio Pharmaceutical Business Overview
  16. 8.3.3 Hybio Pharmaceutical GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hybio Pharmaceutical GnRH Analogues Product Portfolio
  18. 8.3.5 Hybio Pharmaceutical Recent Developments
  19. 8.4 Luye Pharma
  20. 8.4.1 Luye Pharma Company Information
  21. 8.4.2 Luye Pharma Business Overview
  22. 8.4.3 Luye Pharma GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Luye Pharma GnRH Analogues Product Portfolio
  24. 8.4.5 Luye Pharma Recent Developments
  25. 8.5 Livzon Pharmaceutical
  26. 8.5.1 Livzon Pharmaceutical Company Information
  27. 8.5.2 Livzon Pharmaceutical Business Overview
  28. 8.5.3 Livzon Pharmaceutical GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Livzon Pharmaceutical GnRH Analogues Product Portfolio
  30. 8.5.5 Livzon Pharmaceutical Recent Developments
  31. 8.6 Beijing Biote Pharmaceutical
  32. 8.6.1 Beijing Biote Pharmaceutical Company Information
  33. 8.6.2 Beijing Biote Pharmaceutical Business Overview
  34. 8.6.3 Beijing Biote Pharmaceutical GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Biote Pharmaceutical GnRH Analogues Product Portfolio
  36. 8.6.5 Beijing Biote Pharmaceutical Recent Developments
  37. 8.7 Tolmar
  38. 8.7.1 Tolmar Company Information
  39. 8.7.2 Tolmar Business Overview
  40. 8.7.3 Tolmar GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tolmar GnRH Analogues Product Portfolio
  42. 8.7.5 Tolmar Recent Developments
  43. 8.8 TerSera Therapeutics
  44. 8.8.1 TerSera Therapeutics Company Information
  45. 8.8.2 TerSera Therapeutics Business Overview
  46. 8.8.3 TerSera Therapeutics GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TerSera Therapeutics GnRH Analogues Product Portfolio
  48. 8.8.5 TerSera Therapeutics Recent Developments
  49. 8.9 Takeda Pharmaceutical
  50. 8.9.1 Takeda Pharmaceutical Company Information
  51. 8.9.2 Takeda Pharmaceutical Business Overview
  52. 8.9.3 Takeda Pharmaceutical GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Takeda Pharmaceutical GnRH Analogues Product Portfolio
  54. 8.9.5 Takeda Pharmaceutical Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi GnRH Analogues Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
  61. 8.11 Praecis Pharmaceuticals
  62. 8.11.1 Praecis Pharmaceuticals Company Information
  63. 8.11.2 Praecis Pharmaceuticals Business Overview
  64. 8.11.3 Praecis Pharmaceuticals GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Praecis Pharmaceuticals GnRH Analogues Product Portfolio
  66. 8.11.5 Praecis Pharmaceuticals Recent Developments
  67. 8.12 Pfizer
  68. 8.12.1 Pfizer Company Information
  69. 8.12.2 Pfizer Business Overview
  70. 8.12.3 Pfizer GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer GnRH Analogues Product Portfolio
  72. 8.12.5 Pfizer Recent Developments
  73. 8.13 Organon Pharmaceutical
  74. 8.13.1 Organon Pharmaceutical Company Information
  75. 8.13.2 Organon Pharmaceutical Business Overview
  76. 8.13.3 Organon Pharmaceutical GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Organon Pharmaceutical GnRH Analogues Product Portfolio
  78. 8.13.5 Organon Pharmaceutical Recent Developments
  79. 8.14 Merck
  80. 8.14.1 Merck Company Information
  81. 8.14.2 Merck Business Overview
  82. 8.14.3 Merck GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Merck GnRH Analogues Product Portfolio
  84. 8.14.5 Merck Recent Developments
  85. 8.15 Ipsen Pharma
  86. 8.15.1 Ipsen Pharma Company Information
  87. 8.15.2 Ipsen Pharma Business Overview
  88. 8.15.3 Ipsen Pharma GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ipsen Pharma GnRH Analogues Product Portfolio
  90. 8.15.5 Ipsen Pharma Recent Developments
  91. 8.16 Fuji Pharma
  92. 8.16.1 Fuji Pharma Company Information
  93. 8.16.2 Fuji Pharma Business Overview
  94. 8.16.3 Fuji Pharma GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Fuji Pharma GnRH Analogues Product Portfolio
  96. 8.16.5 Fuji Pharma Recent Developments
  97. 8.17 Ferring Pharmaceuticals
  98. 8.17.1 Ferring Pharmaceuticals Company Information
  99. 8.17.2 Ferring Pharmaceuticals Business Overview
  100. 8.17.3 Ferring Pharmaceuticals GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Ferring Pharmaceuticals GnRH Analogues Product Portfolio
  102. 8.17.5 Ferring Pharmaceuticals Recent Developments
  103. 8.18 Endo International
  104. 8.18.1 Endo International Company Information
  105. 8.18.2 Endo International Business Overview
  106. 8.18.3 Endo International GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Endo International GnRH Analogues Product Portfolio
  108. 8.18.5 Endo International Recent Developments
  109. 8.19 AstraZeneca
  110. 8.19.1 AstraZeneca Company Information
  111. 8.19.2 AstraZeneca Business Overview
  112. 8.19.3 AstraZeneca GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 AstraZeneca GnRH Analogues Product Portfolio
  114. 8.19.5 AstraZeneca Recent Developments
  115. 8.20 AbbVie
  116. 8.20.1 AbbVie Company Information
  117. 8.20.2 AbbVie Business Overview
  118. 8.20.3 AbbVie GnRH Analogues Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 AbbVie GnRH Analogues Product Portfolio
  120. 8.20.5 AbbVie Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GnRH Analogues Value Chain Analysis
  2. 9.1.1 GnRH Analogues Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GnRH Analogues Production Mode & Process
  6. 9.2 GnRH Analogues Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GnRH Analogues Distributors
  9. 9.2.3 GnRH Analogues Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst